Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02343952 |
|---|---|
| Brief Title: | Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC |
| First Submitted : | January 6, 2015 |
| First Submitted that Met QC Criteria : | January 16, 2015 |
| First Posted : | January 22, 2015 (Estimate) |
| Results First Submitted : | October 22, 2021 |
| Results First Submitted that Met QC Criteria : | December 8, 2021 |
| Results First Posted : | January 6, 2022 |
| Last Update Submitted that Met QC Criteria : | February 17, 2022 |
| Last Update Posted : | February 21, 2022 |